Your browser doesn't support javascript.
loading
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence.
Chabre, Olivier; Muller, Marie; Cristante, Justine; Cracowski, Jean-Luc; Gay, Emmanuel.
Affiliation
  • Chabre O; Université Grenoble Alpes, Service d'Endocrinologie CHU Grenoble Alpes, Unité Mixte de Recherche INSERM-CEA-UGA UMR 1036, Grenoble F-38000, France. Electronic address: olivierchabre@chu-grenoble.fr.
  • Muller M; Service d'Endocrinologie CHU Grenoble Alpes, Grenoble, France.
  • Cristante J; Université Grenoble Alpes, Service d'Endocrinologie CHU Grenoble Alpes, Unité Mixte de Recherche INSERM-CEA-UGA UMR 1036, Grenoble F-38000, France.
  • Cracowski JL; Université Grenoble Alpes Pharmacovigilance Department, INSERM UMR 1300-Laboratory HP2, Grenoble Alpes University, Grenoble, France.
  • Gay E; Université Grenoble Alpes, Service de Neurochirurgie CHU Grenoble Alpes, Grenoble, France.
Lancet Diabetes Endocrinol ; 10(6): 384-385, 2022 06.
Article in En | MEDLINE | ID: mdl-35597254
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pituitary ACTH Hypersecretion Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pituitary ACTH Hypersecretion Limits: Humans Language: En Year: 2022 Type: Article